BOOTHBAY FUND MANAGEMENT, LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 142 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$714,000
+73.3%
40,677
-4.1%
0.02%
+42.9%
Q2 2021$412,000
+6766.7%
42,423
+111.6%
0.01%
+1300.0%
Q3 2019$6,000
-14.3%
20,0440.0%0.00%0.0%
Q2 2019$7,000
-46.2%
20,0440.0%0.00%0.0%
Q1 2019$13,000
-61.8%
20,0440.0%0.00%
-80.0%
Q4 2018$34,000
-70.9%
20,044
-0.4%
0.01%
-58.3%
Q3 2018$117,00020,1250.01%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders